SLI
2.064,65
PKT
-18,09
PKT
-0,87
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
26.04.21 | Holcim overweight | Morgan Stanley | |
26.04.21 | Holcim overweight | Barclays Capital | |
26.04.21 | Holcim overweight | JP Morgan Chase & Co. | |
26.04.21 | Holcim Hold | Jefferies & Company Inc. | |
26.04.21 | Holcim Outperform | Credit Suisse Group | |
26.04.21 | ams-OSRAM Underperform | Credit Suisse Group | |
23.04.21 | Nestlé Neutral | Credit Suisse Group | |
23.04.21 | Roche buy | Goldman Sachs Group Inc. | |
23.04.21 | Holcim overweight | JP Morgan Chase & Co. | |
23.04.21 | UBS Sector Perform | RBC Capital Markets | |
23.04.21 | Roche Halten | DZ BANK | |
23.04.21 | Nestlé kaufen | DZ BANK | |
23.04.21 | UBS buy | Deutsche Bank AG | |
23.04.21 | Nestlé buy | Kepler Cheuvreux | |
23.04.21 | UBS neutral | Kepler Cheuvreux | |
23.04.21 | Nestlé buy | UBS AG | |
23.04.21 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
23.04.21 | Nestlé buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
23.04.21 | Nestlé add | Baader Bank | |
23.04.21 | Nestlé buy | Goldman Sachs Group Inc. | |
23.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
23.04.21 | Nestlé overweight | Barclays Capital | |
22.04.21 | Nestlé Sector Perform | RBC Capital Markets | |
22.04.21 | Roche Neutral | Credit Suisse Group | |
22.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
22.04.21 | Holcim buy | UBS AG | |
22.04.21 | Nestlé Sector Perform | RBC Capital Markets | |
22.04.21 | Nestlé overweight | Morgan Stanley | |
22.04.21 | Nestlé Hold | Jefferies & Company Inc. | |
22.04.21 | Nestlé buy | Goldman Sachs Group Inc. | |
22.04.21 | UBS Neutral | Goldman Sachs Group Inc. | |
22.04.21 | Roche Neutral | Credit Suisse Group | |
22.04.21 | Nestlé overweight | JP Morgan Chase & Co. | |
22.04.21 | UBS Neutral | JP Morgan Chase & Co. | |
21.04.21 | Roche Hold | Jefferies & Company Inc. | |
21.04.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
21.04.21 | Roche overweight | Barclays Capital | |
21.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
21.04.21 | Roche Outperform | Bernstein Research | |
21.04.21 | Swiss Re Outperform | RBC Capital Markets |